EQS-News: SYNLAB AG: SYNLAB delivers robust underlying growth in FY 2022
FY 2022 underlying organic growth (excluding COVID-19 testing revenue) remained strong at 6.2%, with robust volume growth and a minor price increase of 0.6% at Group level.
- FY 2022 underlying organic growth (excluding COVID-19 testing revenue) remained strong at 6.2%, with robust volume growth and a minor price increase of 0.6% at Group level.
- This is well above the guidance of 3%+ year-on-year organic growth and demonstrates the ability of SYNLAB to consistently execute its underlying growth strategy.
- Underlying organic growth was 6.4% at Group level with an accelerating price increase of 1.4% (compared to 1% in Q3 2022).
- FY 2022 adjusted EPS was €1.54 (FY 2021: €3.14) based on a weighted average of 221,558,169 shares outstanding in FY 2022 and 215,159,817 in FY 2021 respectively.